drugset / Trial / NCT06368804

Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis

NCT06368804

RandomizedParallel-groupOpen-labelTreatment

Summary

Chronic airways infection with Pseudomonas aeruginosa (PA) is associated with increased frequency of exacerbations, deterioration in quality of life and increased mortality in adult patients with bronchiectasis. Current guidelines suggest the prescription of an eradication antibiotic treatment for a first episode of PA infection (early PA infection). Several antibiotic regimens may be proposed, ranging from a monotherapy with oral fluoroquinolone (FQ) to an intravenous cotherapy with the addition of inhaled antibiotics that seems to improve the rate of PA eradication. As no study strictly favoured one regimen, current practices are heterogeneous and could certainly benefit from stronger evidence, with both medical and economic impact.

Timeline

Start
2024-09-15
Primary completion
2025-03-15
Completion
2028-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftazidime Small molecule 4 g Intravenous
Comparator Ceftazidime Small molecule 6 g Intravenous
Background Ciprofloxacin Small molecule 750 mg Oral
Background Colistimethate Unknown 1e+06 iu Inhaled

Indications